IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient

Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 244(2022) vom: 21. Nov., Seite 109130
1. Verfasser: Mountz, John D (VerfasserIn)
Weitere Verfasser: Gao, Min, Ponder, David M, Liu, Shanrun, Sun, Chiao-Wang, Alduraibi, Fatima, Sullivan, Kathryn, Pat, Betty, Dell'Italia, Louis J, Hsu, Hui-Chen
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Case Reports Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural COVID-19 vaccination Dupilumab IL-4 receptor Memory B cells Naive B cells mehr... Antibodies, Monoclonal Antibodies, Monoclonal, Humanized COVID-19 Vaccines Receptors, Antigen, B-Cell Receptors, Interleukin-4 Interleukin-4 207137-56-2 dupilumab 420K487FSG RNA 63231-63-0